Skip to content
value.today
PolyNovo Limited logo

PolyNovo Limited

PNV.AX
$1.8 Bmarket cap on Aug 1, 2026+139.9% since Jan 2024
Compare
World rank
#6,799
Revenue
$16 M
Jun-2020 ending year
value.today research
Net income
$-3 M
-18.5% margin
value.today research
Employees
—

PolyNovo Limited in brief

PolyNovo Limited is a listed company in the Biotechnology industry, based in Australia. Its market value was $1.8 B on 1 August 2026, which makes it the 6,799th largest listed company in the world and the 138th largest in Australia on this site. In the year to Jun 2020 it had sales of $16 M and a net loss of $3 M. Its shares trade under the symbol PNV.AX (ASX).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About PolyNovo Limited

Medical device company with headquarters is in Australia.

PolyNovo Limited timeline

1 events, 1998
  1. 1998
  2. 🔔
    Initial public offering on Australian Securities Exchange as PNV

Events of PolyNovo Limited from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$532 M$1.1 B$1.6 B$2.1 B2020202120222023202420252026

World rank over time

▲ up 1,301 places since 2020
2020-01-01: #8049#8,04920202021-01-01: #5510#5,51020212022-12-25: #8983#8,98320222023-07-30: #10474#10,47420232024-01-05: #10177#10,17720242026-08-01: #6748#6,7482026

Rank in Australia: #170 (Jan 2020) · #124 (Jan 2021) · #180 (Dec 2022) · #217 (Jul 2023) · #205 (Jan 2024) · #139 (Aug 2026)

Annual results

Revenue
$16 M
Operating income
—
Net income
$-3 M

Jun-2020 ending year

Mutual funds holding PolyNovo Limited#

18 funds in 2 countries hold shares worth $17 M (about 0.9% of the company). Since their previous reports 10 added shares and 12 sold, selling $6 M net. By country: USA 17 ($16 M), Sweden 1 ($0 M).
Mutual funds holding PolyNovo Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.8.91 M$5 M0.30%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Developed Markets Index FundThe Vanguard Group, Inc.5.96 M$4 M0.20%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc.2.70 M$2 M0.09%0.01%+13%Jul 31, 2026
🇺🇸 Schwab International Small-Cap Equity ETFCharles Schwab Investment Management, Inc.1.37 M$1 M0.05%0.02%+4.8%May 31, 2026
🇺🇸 Polar Capital International Small Company FundPolar Capital LLP1.77 M$1 M0.06%0.87%−4.1%Jun 30, 2026
🇺🇸 State Street SPDR Portfolio Developed World ex-US ETFSSGA Funds Management, Inc.1.73 M$1 M0.06%<0.01%−0.1%Jun 30, 2026
🇺🇸 The Asia Pacific Small Company SeriesDimensional Fund Advisors LP1.26 M$1 M0.04%0.04%newJul 31, 2026
🇺🇸 Vanguard Pacific Stock Index FundThe Vanguard Group, Inc.675,280$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.652,283$0 M0.02%<0.01%+72%Jul 31, 2026
🇸🇪 Handelsbanken Global Småbolag Index CriteriaHandelsbanken Fonder AB586,442$0 M0.02%0.01%+48%Jun 30, 2026
🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc.402,749$0 M0.01%0.03%+1.0%Jun 30, 2026
🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc.112,097$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust52,589$0 M<0.01%0.02%newMay 31, 2026
🇺🇸 iShares MSCI World Small-Cap ETFBlackRock Fund Advisors46,291$0 M<0.01%<0.01%−25%May 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP25,794$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 International Small Cap Growth PortfolioDimensional Fund Advisors LP15,529$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP8,262$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Core Equity Market ETFDimensional Fund Advisors LP4,095$0 M<0.01%<0.01%newJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 18 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where PolyNovo Limited operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for PolyNovo Limited: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

PolyNovo Limited: countries of operation
CountryPresenceRevenue there
🇦🇺 AustraliaHeadquarters—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Discuss PolyNovo Limited#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 18 funds hold $17 millionautomatic update · Jul 31, 2026

    18 mutual funds in 2 countries hold shares of PolyNovo Limited worth $17 million, about 0.9% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 10 funds added shares and 12 sold; on balance they sold $6 million. Share splits are not counted as trading.

How PolyNovo Limited compares in Biotechnology

  • Market cap$1.8 B · higher than 77% of 726
  • Revenue$16 M · higher than 48% of 647
  • Net margin-18.5% · higher than 62% of 408
  • Price / sales109.6× · lower than 9% of 339

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
PolyNovo Limited🇦🇺$1.8 B—-18.5%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Aug 1, 2026
Annual results:
Jun-2020 ending year
Balance sheet:
Jun-2020 ending year
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research, Wikidata.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at PolyNovo Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show PolyNovo Limited's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about PolyNovo Limited? Suggest a correction